Leaflet: information for the user
Dolifen11.6 mg/g gel
diclofenac, diethylamine
Read the entire leaflet carefully before starting to use the medicine,as it contains important information for you. Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
|
Contents of the leaflet:
Diclofenac diethylamine, the active ingredient of this medicine, belongs to the group of non-steroidal anti-inflammatory drugs and acts as a local analgesic and anti-inflammatory.
This medicine is indicated in adults and adolescents over 14 years old for the local relief of mild and occasional pain and inflammation caused by:
Do not use Dolifen:
The symptoms related to an allergic reaction to these medicines can be: asthma, difficulty breathing, skin rash or itching, swelling in the face or tongue
Warnings and precautions
Children and adolescents
Do not use in children under 14 years old.
Other medicines and Dolifen
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Consult your doctor or pharmacist before using any medicine.
Do not use Dolifen gel if you are in the last 3 months of pregnancy, as it may harm the unborn baby or cause problems during delivery.
Do not use Dolifen gel during the first 6 months of pregnancy, unless it is strictly necessary and recommended by your doctor. If you need treatment during this period, you should use the minimum possible dose for the shortest possible time.
The oral formulations (e.g., tablets) of diclofenac may cause adverse reactions to the fetus. It is not known if this same risk applies to Dolifen gel when used on the skin.
Breastfeeding
Consult your doctor or pharmacist before using any medicine.
During breastfeeding, do not use this medicine, unless your doctor has indicated it, as diclofenac passes into breast milk in small amounts.
Do not apply it in any case to breastfeeding mothers directly on the breast area, or on other areas in large areas of the skin or for prolonged periods of time.
Driving and using machines
No effects of the medicine on the ability to drive vehicles or use machinery have been described.
Dolifen contains propylene glycol(E 1520)
This medicine contains 200 mg of propylene glycol (E 1520) in 4 g of gel, equivalent to 50 mg/g. Propylene glycol may cause skin irritation.
Follow exactly the administration instructions of this medicine contained in this leaflet or as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
This medicine is for application on the skin (cutaneous use).
The recommended dose is:
Adults and adolescents over 14 years old:
Apply 3 or 4 times a day a small amount of gel to the inflamed or painful area.
The amount of gel will vary depending on the size of the affected area (normally, it will be sufficient to apply an amount similar to the size of a cherry or a walnut).
Use the minimum amount for the minimum time necessary.
Mode of use:
After application:
If the pain or swelling worsens or persists after 7 days of treatment, consult your doctor.
If you use more Dolifen than you should
If you have applied too much of the medicine, it is recommended to remove it by washing the affected area with plenty of water.
If you accidentally ingest the gel or if you have used it on a large area of the skin and for a long period of time, adverse reactions similar to those produced by diclofenac when taken orally (e.g., tablets) may occur.
The main symptoms of overdose are: gastrointestinal or kidney disorders and difficulty breathing.
In case of overdose or accidental ingestion, go immediately to your doctor, pharmacist, or call the Toxicology Information Service, Phone: 91 562 04 20, indicating the medicine and the amount ingested. It is recommended to take the package and the leaflet of the medicine to the healthcare professional.
If you forget to use Dolifen
If you forgot to apply this medicine when it was due, apply the gel as soon as possible and continue the treatment normally.
Do not apply a double dose to make up for the forgotten doses.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Some rare and very rare side effects can be serious:
If you suffer from any serious side effect, stop the treatment with this medicine and inform your doctor immediately.
Rare:May affect up to 1 in 1,000 patients
Very rare:May affect up to 1 in 10,000 patients
Non-serious side effects
Other side effects may occur, but they are usually mild and temporary. If you notice any of them, consult your doctor or pharmacist as soon as possible.
Common:May affect up to 1 in 10 patients.
Very rare:May affect up to 1 in 10,000 patients
Frequency not known:Cannot be estimated from the available data
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines (www.notificaRAM.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiration date stated on the package, after EXP. The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Dolifen
Appearance of the product and package contents
White, consistent, homogeneous gel with a characteristic odor of lavender and isopropyl alcohol. It is presented in a sealed aluminum tube with an aluminum membrane and a screw cap made of polypropylene.
Each tube contains 60 grams of gel.
Marketing authorization holder:
Faes Farma, S.A.
Autonomia Etorbidea, 10
48940 Leioa (Bizkaia)
Spain
Manufacturer:
Faes Farma Portugal, S.A.
Rua Elias García, 28
2700-327 Amadora
Portugal
Date of the last revision of this leaflet:09/2024
Other sources of information
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es./
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DOLIFEN 11.6 mg/g GEL – subject to medical assessment and local rules.